Deletions of TET2 and loss of heterozygosity or uni-parental disomy was observed in (9%) MDS/AML patients with mutated TET2[70], where it is likely for the wild-type allele to be lost during recombination, allowing mutated TET2 to promote a loss of function phenotype. Here, TET2 is linked to myelodysplastic syndrome.